IP Library Granted Patent US 7,691,918
Granted Patent B2
US 7,691,918 · App. 11/871,411 · Granted Apr 6, 2010

Intraocular lenses with unique blue-violet cutoff and blue light transmission characteristics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,691,918
App. No.
11/871,411
Granted
Apr 6, 2010
Kind
B2
Abstract

Disclosed are ophthalmic device materials having improved light transmission characteristics. The materials contain a combination of certain UV absorbers and blue-light absorbing chromophores.

Claims (119)

1. An ophthalmic device material comprising

a) a UV/short wavelength visible light absorber of formula (I)

 wherein for formula (I)

R 1 is a halogen, OH, C 1 -C 12 alkyloxy, optionally substituted phenoxy, or optionally substituted napthyloxy, where the optional substituents are C 1 -C 6 alkyl, C 6 -C 6 alkoxy, OH, —(CH 2 CH 2 O) n —, or —(CH 2 CH(CH 3 )O) n —;

R 2 is a C 1 -C 12 alkyl, (CH 2 CH 2 O) n , (CH 2 CH(CH 3 )O) n , or

CH 2 CH 2 CH 2 (Si(CH 3 ) 2 O) m Si(CH 3 ) 2 CH 2 CH 2 CH 2 ;

X is nothing if R 2 is (CH 2 CH 2 O) n or (CH 2 CH(CH 3 )O) n , otherwise X is O, NR 4 ,

or S;

R 3 is nothing, C(═O), C(═O)C j H 2j , C 1 -C 6 alkyl, phenyl, or C 1 -C 6 alkylphenyl;

R 4 is H or methyl;

R 5 is H, C 1 -C 6 alkyl, or phenyl;

R 6 is H or C 1 -C 12 alkyl;

n is 2-10; and

j is 1-6;

b) a polymerizable yellow dye that attenuates light having wavelengths in the range 430-500 nm wherein the polymerizable yellow dye is selected from the group consisting of dyes of formula (II): dyes of formula (III); and

 wherein for formula (II)

R′ and R″ independently are H or CH 3 ;

R 6 and R 7 independently are H, C 1 -C 20 alkyl, OCH 3 , OC 2 H 5 , OC 3 H 7 , or OC 4 H 9 ;

i and j independently are 1 or 2;

R 8 and R 9 , R 10 and R 11 independently are an acyclic organic spacing group of up to 10 atoms which is composed of carbon, hydrogen, silicon, oxygen, nitrogen, phosphorous, sulfur, chloride, bromine, or fluorine alone or in any combination;

k and m independently are 1 to 6;

l and n independently are 0 to 6;

X is O, NH, NR 5 ; and

R 5 ═C 1 to C 10 alkyl;

wherein for formula (III)

R is H or CH 3 ;

R 1 is H, C 1 -C 20 alkyl, OCH 3 , OC 3 H 7 , or OC 4 H 9 ;

a and b are independently 1 or 2;

R 2 is R 1 , OH, NH 2 , NHR 5 , N(R 5 ) 2 , SH, SR 5 , OR 5 , OSi(R 5 ) 3 , or Si(R 5 ) 3 ;

R 3 is directly attached to the dye moiety and consists of an alkyl group of up to 6 carbon atoms;

R 4 is an acyclic organic spacing group of up to 10 atoms which is composed of carbon, hydrogen, silicon, oxygen, nitrogen, phosphorous, sulfur, chloride, bromine, or fluorine alone or in any combination;

X is O, NH, NR 5 ;

R 5 is C 1 to C 10 alkyl;

d, e, g, and h independently are an integer from 0 to 4; and

c and f independently are an integer from 1 to 4;

and wherein the amount of UV/short wavelength visible light absorber is from 1-3% (wt.) and the amount of polymerizable yellow dye is from 0.01-0.1% (wt.);

c) a device-forming monomer in an amount of 75% (wt.) or more; and

d) a cross-linking agent, wherein the amount of the UV/short wavelength visible light absorber and the amount of the polymerizable yellow dye are sufficient to cause the ophthalmic device material to have the following light transmission characteristics:

Ranges of Transmission

Characteristics*

Transmission

Maximum

Blue light region

Characteristic

Minimum value

value

Blue-violet cutoff

 1% T

410 nm

430 nm

10% T

420 nm

440 nm

Mid-blue

440 nm

10% T

75% T

transition region

450 nm

28% T

80% T

460 nm

40% T

85% T

High transmission

470 nm

55% T

95% T

blue light region

480 nm

68% T

95% T

490 nm

80% T

95% T

500 nm

85% T

 95% T.

*determined by UV-Visible measurements in air.

2. The ophthalmic device material of claim 1 wherein in formula (I)

R 1 is Cl, Br, C 1 -C 4 alkoxy, or phenoxy;

R 2 is C 1 -C 6 alkyl;

X is O or NR 4 ;

R 3 is C(═O) or C 1 -C 6 alkylphenyl;

R 4 is H or methyl;

R 5 is H; and

R 6 is C 4 -C 12 t-alkyl.

3. The ophthalmic device material of claim 2 wherein in formula (I)

R 1 is methoxy;

R 2 is C 2 -C 3 alkyl;

X is O;

R 3 is C(═O);

R 4 is H or methyl;

R 5 is H; and

R 6 is t-butyl.

4. The ophthalmic device material of claim 1 wherein the UV/short wavelength visible light absorber of formula (I) is selected from the group consisting of 2-{2′-Hydroxy-3′-tert-butyl-5′[3″-(4′″-vinylbenzyloxy)propoxy]phenyl}-5-methoxy-2H-benzotriazole and 2-[2′-hydroxy-3′-tert-butyl-5′-(3″-methacryloyloxypropoxy)phenyl]-5-methoxy-2H-benzotriazole.

5. The ophthalmic device material of claim 1 wherein the polymerizable yellow dye is selected from the group consisting of N,N-bis- (2-methacroyloxyethyl)-(4-phenylazo)aniline and N-2-[3-(2′-methylphenylazo)-4-Hydroxyphenyl]ethyl methacrylamide.

6. The ophthalmic device material of claim 1 wherein the amount of UV/short wavelength visible light absorber is from 1.5-2.5% (wt.).

7. The ophthalmic device material of claim 1 wherein the amount of polymerizable yellow dye is from 0.01-0.05% (wt.).

8. The ophthalmic device material of claim 1 wherein the device-forming monomer is selected from the group consisting of acrylic and silicone-containing monomers.

9. The ophthalmic device material of claim 8 wherein the device-forming monomer is a monomer of formula (IV)

wherein for formula (IV):

A is H, CH 3 , CH 2 CH 3 , or CH 2 OH;

B is (CH 2 ) m or [O(CH 2 ) 2 ] z ;

C is (CH 2 ) w ;

m is 2-6;

z is 1-10;

Y is nothing, O, S, or NR′, provided that if Y is O, S, or NR′, then B is (CH 2 ) m ;

R′ is H, CH 3 , C n′ H 2n′+1 (n′=1-10), iso-OC 3 H 7 , C 6 H 5 , or CH 2 C 6 H 5 ;

w is 0-6, provided that m+w≦8; and

D is H, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 6 H 5 , CH 2 C 6 H 5 or halogen.

10. The ophthalmic device material of claim 9 wherein for formula (IV)

A is H or CH 3 , B is (CH 2 ) m , m is 2-5, Y is nothing or O, w is 0-1, and D is H.

11. The ophthalmic device material of claim 10 wherein the device-forming monomer is selected from the group consisting of 2-phenylethyl methacrylate; 4-phenylbutyl methacrylate; 5-phenylpentyl methacrylate; 2-benzyloxyethyl methacrylate; and 3-benzyloxypropyl methacrylate; and their corresponding acrylates.

12. The ophthalmic device material of claim 1 wherein the cross-linking agent is selected from the group consisting of ethylene glycol dimethacrylate; diethylene glycol dimethacrylate; allyl methacrylate; 1,3-propanediol dimethacrylate; 2,3-propanediol dimethacrylate; 1,6-hexanediol dimethacrylate; 1,4-butanediol dimethacrylate; CH 2 ═C(CH 3 )C(═O)O—(CH 2 CH 2 O) p -C(═O)C(CH 3 )═CH 2 where p=1-50; and CH 2 ═C(CH 3 )C(═O)O(CH 2 ) t O—C(═O)C(CH 3 )═CH 2 where t=3-20; and their corresponding acrylates.

13. The ophthalmic device material of claim 1 wherein the amount of cross-linking agent is 0.1-20% (wt.).

14. An ophthalmic device comprising the material of claim 1 wherein the ophthalmic device is selected from the group consisting of intraocular lenses; contact lenses; keratoprostheses; or corneal rings or inlays.

15. The ophthalmic device material of claim 1 wherein R 1 is OH, C 1 -C 12 alkyloxy, optionally substituted phenoxy, or optionally substituted napthyloxy, where the optional substituents are C 1 -C 6 alkyl, C 1 -C 6 alkoxy, OH, —(CH 2 CH 2 O) n —, or —(CH 2 CH(CH 3 )O) n —.

16. The ophthalmic device material of claim 1 wherein the device material has an elongation (strain at break) of at least 100% and the glass transition temperature of the device material is below about 15° C.

Assignments (5)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
MERGER Recorded May 31, 2011
From: ALCON, INC.
To: NOVARTIS AG
Reel/Frame 026376/0076 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2008
From: ALCON RESEARCH, LTD.
To: ALCON, INC.
Reel/Frame 021423/0785 →
MERGER Recorded Jul 21, 2008
From: ALCON MANUFACTURING, LTD.
To: ALCON RESEARCH, LTD.
Reel/Frame 021266/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2007
From: JINKERSON, DAVID L.; WEINSCHENK, JOSEPH I., III; KARAKELLE, MUTLU
To: ALCON MANUFACTURING, LTD.
Reel/Frame 019954/0681 →